• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典心脏病循证护理增强和发展网络系统(SWEDEHEART),评估依据为推荐疗法。

The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART).

机构信息

Department of Cardiology, Karolinska University Hospital, Huddinge, Institution of Medicine (H7), Huddinge, Karolinska Institutet, Stockholm 141 86, Sweden.

出版信息

Heart. 2010 Oct;96(20):1617-21. doi: 10.1136/hrt.2010.198804. Epub 2010 Aug 27.

DOI:10.1136/hrt.2010.198804
PMID:20801780
Abstract

AIMS

The aims of the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) are to support the improvement of care and evidence-based development of therapy of coronary artery disease (CAD).

INTERVENTIONS

To provide users with online interactive reports monitoring the processes of care and outcomes and allowing direct comparisons over time and with other hospitals. National, regional and county-based reports are publicly presented on a yearly basis.

SETTING

Every hospital (n=74) in Sweden providing the relevant services participates. Launched in 2009 after merging four national registries on CAD.

POPULATION

Consecutive acute coronary syndrome (ACS) patients, and patients undergoing coronary angiography/angioplasty or heart surgery. Includes approximately 80, 000 new cases each year.

STARTPOINTS

On admission in ACS patients, at coronary angiography in patients with stable CAD.

BASELINE DATA

106 variables for patients with ACS, another 75 variables regarding secondary prevention after 12-14 months, 150 variables for patients undergoing coronary angiography/angioplasty, 100 variables for patients undergoing heart surgery.

DATA CAPTURE

Web-based registry with all data registered online directly by the caregiver.

DATA QUALITY

A monitor visits approximately 20 hospitals each year. In 2007, there was a 96% agreement.

ENDPOINTS AND LINKAGES TO OTHER DATA

Merged with the National Cause of Death Register, including information about vital status of all Swedish citizens, the National Patient Registry, containing diagnoses at discharge for all hospital stays in Sweden and the National Registry of Drug prescriptions recording all drug prescriptions in Sweden.

ACCESS TO DATA

Available for research by application to the SWEDEHEART steering group.

摘要

目的

瑞典基于推荐疗法评估的心脏病循证护理增强与发展网络系统(SWEDEHEART)的目的是支持改善护理和循证治疗冠状动脉疾病(CAD)。

干预措施

为用户提供在线交互式报告,监测护理过程和结果,并允许与时间和其他医院进行直接比较。国家、地区和县级报告每年都会公开呈现。

设置

瑞典提供相关服务的每家医院(n=74)都参与其中。该系统于 2009 年在合并了四个关于 CAD 的国家登记处后推出。

人群

连续急性冠状动脉综合征(ACS)患者,以及接受冠状动脉造影/血管成形术或心脏手术的患者。每年约有 80,000 例新病例。

起点

ACS 患者入院时,稳定 CAD 患者行冠状动脉造影时。

基线数据

ACS 患者 106 个变量,12-14 个月后二级预防的另外 75 个变量,冠状动脉造影/血管成形术患者 150 个变量,心脏手术患者 100 个变量。

数据采集

基于网络的注册系统,所有数据均由护理人员在线直接注册。

数据质量

监测员每年大约访问 20 家医院。2007 年,有 96%的一致性。

终点和与其他数据的联系

与国家死因登记处合并,包括所有瑞典公民的生命状态信息,国家患者登记处,包含瑞典所有住院治疗的出院诊断,以及国家药物处方登记处,记录瑞典所有药物处方。

数据访问

可通过向 SWEDEHEART 指导小组申请获得研究。

相似文献

1
The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART).瑞典心脏病循证护理增强和发展网络系统(SWEDEHEART),评估依据为推荐疗法。
Heart. 2010 Oct;96(20):1617-21. doi: 10.1136/hrt.2010.198804. Epub 2010 Aug 27.
2
The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART).瑞典心脏病注册研究(SWEDEHEART)2011 年结果。
Scand Cardiovasc J. 2013 Jun;47 Suppl 62:1-10. doi: 10.3109/14017431.2013.780389.
3
Angiographic findings and survival in patients undergoing coronary angiography due to sudden cardiac arrest in western Sweden.瑞典西部因心脏骤停接受冠状动脉造影的患者的血管造影结果与生存率
Resuscitation. 2015 May;90:13-20. doi: 10.1016/j.resuscitation.2014.11.034. Epub 2015 Feb 16.
4
Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008.心力衰竭合并急性心肌梗死的发生率、时间趋势和预后影响。SWEDEHEART 注册研究(瑞典基于推荐治疗的心脏病强化和发展证据的网络系统评估):一项对 1996 年至 2008 年期间 199851 例急性心肌梗死患者的研究。
JACC Heart Fail. 2015 Mar;3(3):234-42. doi: 10.1016/j.jchf.2014.10.007.
5
Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).当代 ticagrelor 在急性冠脉综合征患者中的应用:来自瑞典基于推荐疗法评估的心脏病增强和循证医疗开发网络系统(SWEDEHEART)的见解。
Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):5-12. doi: 10.1093/ehjcvp/pvv034. Epub 2015 Aug 28.
6
Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).瑞典西部急性心肌梗死后心脏护理与预后的性别差异趋势:来自瑞典心脏病循证护理强化网络系统(SWEDEHEART)的报告,该系统根据推荐疗法进行评估
J Am Heart Assoc. 2015 Jul 14;4(7):e001995. doi: 10.1161/JAHA.115.001995.
7
Socioeconomic Factors, Secondary Prevention Medication, and Long-Term Survival After Coronary Artery Bypass Grafting: A Population-Based Cohort Study From the SWEDEHEART Registry.社会经济因素、二级预防药物治疗与冠状动脉旁路移植术后的长期生存:来自 SWEDEHEART 注册登记研究的一项基于人群的队列研究。
J Am Heart Assoc. 2020 Mar 3;9(5):e015491. doi: 10.1161/JAHA.119.015491. Epub 2020 Mar 2.
8
Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes: from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).在非 ST 段抬高型急性冠状动脉综合征的男性和女性中,采用侵入性策略的结果相似:来自瑞典的 Web 系统,用于增强和发展心脏病推荐治疗的循证护理(SWEDEHEART)。
Eur Heart J. 2011 Dec;32(24):3128-36. doi: 10.1093/eurheartj/ehr349. Epub 2011 Sep 11.
9
Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.过去 20 年中,非 ST 段抬高型心肌梗死患者新治疗方法的实施与改善结局之间的关系:来自 SWEDEHEART 注册研究 1995 至 2014 年的经验。
Eur Heart J. 2018 Nov 7;39(42):3766-3776. doi: 10.1093/eurheartj/ehy554.
10
Instantaneous Wave-Free Ratio versus Fractional Flow Reserve guided intervention (iFR-SWEDEHEART): Rationale and design of a multicenter, prospective, registry-based randomized clinical trial.瞬时无波比与血流储备分数指导的干预(iFR-SWEDEHEART):一项多中心、前瞻性、基于注册研究的随机临床试验的原理与设计
Am Heart J. 2015 Nov;170(5):945-50. doi: 10.1016/j.ahj.2015.07.031. Epub 2015 Aug 15.

引用本文的文献

1
Anticoagulation and antiplatelet strategies used in Sweden in patients with myocardial infarction and concomitant atrial fibrillation: nationwide cohort study.瑞典心肌梗死合并心房颤动患者的抗凝和抗血小板策略:全国队列研究
Open Heart. 2025 Aug 31;12(2):e003472. doi: 10.1136/openhrt-2025-003472.
2
Helicobacter pylori Screening After Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI SWEDEHEART Trial.急性心肌梗死后幽门螺杆菌筛查:群组随机交叉HELP-MI瑞典心脏注册研究试验
JAMA. 2025 Sep 1. doi: 10.1001/jama.2025.15047.
3
Prognostic Implications of Preoperative N-Terminal Pro-B-Type Natriuretic Peptide Dynamics in Patients Undergoing Cardiac Surgery.
心脏手术患者术前N端前体B型利钠肽动态变化的预后意义
JACC Adv. 2025 Aug 26;4(9):102096. doi: 10.1016/j.jacadv.2025.102096.
4
Registry or randomization - must it be evidence or could it be coincidence?登记或随机分组——这一定是有依据的,还是可能只是巧合?
Innov Surg Sci. 2024 Jun 26;10(2):65-71. doi: 10.1515/iss-2022-0028. eCollection 2025 Jun.
5
Correcting for case-mix shift when developing clinical prediction models.在开发临床预测模型时校正病例组合偏移。
BMC Med Res Methodol. 2025 Aug 1;25(1):186. doi: 10.1186/s12874-025-02621-2.
6
Major Bleeding and Thromboembolic Events with the On-X Mechanical Aortic Valve Prosthesis: A SWEDEHEART Study.On-X机械主动脉瓣假体相关的大出血和血栓栓塞事件:一项瑞典心脏注册研究。
Interdiscip Cardiovasc Thorac Surg. 2025 Aug 5;40(8). doi: 10.1093/icvts/ivaf182.
7
Assessing the Safety, Feasibility, and Clinical Outcomes of a Fast-Track Strategy in Open Cardiac Surgery.评估心脏直视手术快速康复策略的安全性、可行性及临床结局。
Eur J Cardiothorac Surg. 2025 Aug 1;67(8). doi: 10.1093/ejcts/ezaf238.
8
Comparative outcomes of transcatheter aortic valve replacement in bicuspid vs. tricuspid aortic valve stenosis patients: insights from the SWEDEHEART registry.二叶式与三叶式主动脉瓣狭窄患者经导管主动脉瓣置换术的比较结果:来自瑞典心脏注册研究的见解
Int J Cardiol Heart Vasc. 2025 May 14;59:101705. doi: 10.1016/j.ijcha.2025.101705. eCollection 2025 Aug.
9
Clinical and Angiographic Profile of Acute Coronary Syndrome: Insights From a Tertiary Care Center in an Industrial Area.急性冠状动脉综合征的临床及血管造影特征:来自工业区一家三级医疗中心的见解
Cureus. 2025 May 9;17(5):e83805. doi: 10.7759/cureus.83805. eCollection 2025 May.
10
Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries.坚持使用二级预防药物对伴有和不伴有阻塞性冠状动脉的心肌梗死患者预后的影响。
PLoS One. 2025 May 29;20(5):e0324533. doi: 10.1371/journal.pone.0324533. eCollection 2025.